期刊文献+

反义细胞外信号调节激酶-2基因治疗移植物动脉血管病内膜病变 被引量:5

The effect of adenovirus-mediated anti-extracellular signal regulated kinase 2 gene therapy on intimal change in transplant arteriosclerosis
原文传递
导出
摘要 目的观察移植物动脉血管病(TA)的内膜病变机制和反义细胞外信号调节激酶2基因腺病毒载体(Adanti.ERK2)基因治疗的效果。方法建立Brown.Norway(BN)-Lewis移植物动脉血管病模型,分为同系组、Control组、LacZ组和Adanti—ERK2组(给予5×10^9pfuAdanti—ERK2基因治疗),每组各6例。术后60d检测各组内膜病变和血管腔内膜/(内膜+中膜)比,α-肌动蛋白(d—actin)和血小板源性生长因子.BB(PDGF—BB)染色检测移植动脉平滑肌细胞(VSMCs)增殖和分泌功能,评估移植动脉新生毛细血管情况并检测移植动脉中环氧化酶.2(COX-2)的表达。结果术后60d同系组内膜无异常,Control组和LaeZ组典型内膜增殖改变,Adanti—ERK2组内膜病变较轻;内膜/(内膜+中膜)比各组分别为7.6%、81.4%、85.9%、15.9%;α-actin阳性细胞(内膜平滑肌细胞)每视野计数各组分别为0、71.3±9.2、76.4±11.3、34.8±5.3;PDGF—BB阳性细胞每视野计数各组分别为0.9±0.5、28.4±3.4、29.1±3.2、8.6±1.7;移植动脉中膜和内膜新生毛细血管检测各组分别无、丰富、丰富、少量;COX.2新生血管阳性细胞计数各组分别为0、36.3±8.3、40.9±9.2、10.4±3.9。Adanti.ERK2组与其他组别间比较,差异有统计学意义(P〈0.05)。结论内膜增生,血管腔缩窄,PDGF.BB诱导内膜平滑肌细胞募集分化并激发血管新生是TA重要病理生理环节,Adanti—ERK2基因治疗可有效干预各发病环节,达到治疗效果。 Objective To explore the mechanisms of intimal injury underlying transplant arterio- sclerosis (TA) and to clarify the treatment effect of adenovirus-mediated anti-extracellular signal regulated kinase 2 (Adanti-ERK2) gene therapy on TA. Methods The Brown-Norway (BN)-Lewis TA model was employed. According to different gene therapy, the recipients were divided into isograft group, control group, LacZ group, which were used as control, and Adanti-ERK2 group (5 ×10^9 pfu Adanti-ERK2 was transferred into the graft before transplant, 6 cases in each group). The grafts were harvested on the day 60 post-transplantation to evaluate the intimal injury and calculate the ratio of intima/( intima + media). The staining of ct-actin and PDGF-BB was performed to analyze proliferation and secretion of vascular smooth muscle cells (VSMCs). The angiogenesis was evaluated and the cyclooxygenaseo2 (COX-2) staining was detected. Results The intima was normal in the isograft group but a typical intimal proliferation was ob- served in the control group and the LacZ group. A mild intima injury was obtained in the Adanti-ERK2 group. The ratio of intima/( intima + media) was 7.6%, 81.4%, 85.9% and 15.9% in isograft, con- trol, LaeZ and Adanti-ERK2 groups, respectively. The α-aetin staining-positive calls, which indicated VSMCs, were counted per vision-field as O, 71.3 ±9.2, 76.4 ± 11.3 and 34. 8 ±5.3, respectively. The platelet derived growth faetor-BB ( PDGF-BB ) positive cells were counted as 0. 9 ± 0. 5, 28.4± 3.4, 29. 1 ± 3.2 and 8. 6 ±1.7, respectively. The angiogenesis was detected as none, abundant, abundant and few, and COX-2 positive cells were counted as 0, 36. 3 ± 8.3, 40. 9 ± 9. 2 and 10. 4 ± 3.9, respectively (P 〈 0.05 between Adanti-ERK2 group and other groups). Conclusion Intimal proliferation, luminal narrow, VSMCs recruitment and differentiation induced by PDGF-BB in intima and the following angiogene- sis are the important pathophysiological process of TA. Adanti-
作者 赵波 宫念樵
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2011年第4期514-516,共3页 Chinese Journal of Experimental Surgery
基金 基金项目:国家自然科学基金资助项目(30300324) 武汉市科技攻关计划资助项目(201060948360-03)
关键词 移植物动脉血管病 内膜 血管新生 ERK2 基因治疗 Transplant arteriosclerosis Intima Angiogenesis ERK2 Gene therapy
  • 相关文献

参考文献10

二级参考文献55

  • 1董冲,刘云,宫念樵,陈曦林,唐莉,朱国超,陈知水,叶启发.反向克隆法大鼠anti-ERK2腺病毒载体构建[J].中国现代医学杂志,2006,16(1):21-23. 被引量:4
  • 2高锐,辛宇鹏,卢一平,王佳,李幼平.不同免疫抑制剂对大鼠血管平滑肌细胞转化生长因子-β1和Smads信号通路的影响及意义[J].中华实验外科杂志,2006,23(8):965-967. 被引量:4
  • 3向志,吴忠均,余林,时德.反义c-myc和增殖细胞核抗原抑制移植血管狭窄研究[J].中华实验外科杂志,2007,24(2):144-146. 被引量:4
  • 4Avery RK. Cardiac-allograft vasculopathy. N Engl J Med,2003,349: 829-830. 被引量:1
  • 5Sterpetti AV, Cucina A, Lepidi S, et al. Progression and regression of myointimal hyperplasia in experimental vein grafts depends on platelet-derived growth factor and basic fibroblastic growth factor production. J Vasc Surg, 1996,23:568-575. 被引量:1
  • 6Reilly CF, McFall RC. Platelet-derived growth factor and transforming growth factor-β1 regulate plasminogen activator inhibitor-1 synthesis in vascular smooth muscle cells. J Biol Chem, 1991,266:9419-9427. 被引量:1
  • 7Zegarska J, Paczek L, Pawlowska M, et al. Increased mRNA expression of transforming growth factor beta in the arterial wall of chronically rejected renal allografts in humans. Transplant Proc ,2006,38:115- 118. 被引量:1
  • 8Geraldes P, Sirois MG, Tanguay JF. Specific contribution of estrogen receptors on mitogen-activated protein kinase pathways and vascular cell activation. Circ Res,2003,93:399405. 被引量:1
  • 9Majack RA. Beta-type transforming growth factor specifies organizational behavior in vascular smooth muscle cell cultures. J Cell Biol, 1987,105:465-471. 被引量:1
  • 10Huang J,Kontos CD. Inhibition of vascular smooth muscle cell proliferation, migration, and survival by the tumor suppressor protein PTEN. Arterioseler Thromb Vase Biol,2002 ,22 :745-751. 被引量:1

共引文献19

同被引文献38

引证文献5

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部